LIVANOVA PLC's ticker is LIVN and the CUSIP is G5509L101. A total of 222 filers reported holding LIVANOVA PLC in Q2 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,258,771 | -23.2% | 118,358 | -25.3% | 0.01% | -23.5% |
| Q2 2023 | $8,153,403 | +102.5% | 158,534 | +69.4% | 0.02% | +88.9% |
| Q1 2023 | $4,026,704 | +46.4% | 93,579 | +88.5% | 0.01% | +50.0% |
| Q4 2022 | $2,751,157 | +135.9% | 49,633 | +115.6% | 0.01% | +100.0% |
| Q3 2022 | $1,166,000 | -58.7% | 23,020 | -49.8% | 0.00% | -50.0% |
| Q2 2022 | $2,826,000 | -34.7% | 45,829 | -13.4% | 0.01% | -25.0% |
| Q1 2022 | $4,330,000 | +120.8% | 52,909 | +135.9% | 0.01% | +100.0% |
| Q4 2021 | $1,961,000 | +44.5% | 22,431 | +30.9% | 0.00% | +33.3% |
| Q3 2021 | $1,357,000 | +20.8% | 17,140 | +28.4% | 0.00% | +50.0% |
| Q2 2021 | $1,123,000 | +59.5% | 13,349 | +39.8% | 0.00% | +100.0% |
| Q1 2021 | $704,000 | -52.2% | 9,547 | -57.1% | 0.00% | -66.7% |
| Q4 2020 | $1,474,000 | +230.5% | 22,267 | +119.6% | 0.00% | +200.0% |
| Q3 2020 | $446,000 | -35.5% | 10,138 | -31.4% | 0.00% | 0.0% |
| Q2 2020 | $692,000 | -81.0% | 14,770 | -81.6% | 0.00% | -83.3% |
| Q1 2020 | $3,640,000 | -42.1% | 80,440 | -3.6% | 0.01% | -14.3% |
| Q4 2019 | $6,290,000 | +59.1% | 83,438 | +55.7% | 0.01% | +40.0% |
| Q3 2019 | $3,954,000 | -77.7% | 53,587 | -78.2% | 0.01% | -75.0% |
| Q2 2019 | $17,711,000 | +25.2% | 246,117 | +69.3% | 0.02% | +33.3% |
| Q1 2019 | $14,141,000 | -29.4% | 145,412 | -33.6% | 0.02% | -34.8% |
| Q4 2018 | $20,026,000 | -27.4% | 218,934 | -1.6% | 0.02% | -11.5% |
| Q3 2018 | $27,595,000 | +156.6% | 222,599 | +106.7% | 0.03% | +136.4% |
| Q2 2018 | $10,752,000 | +266.1% | 107,713 | +224.5% | 0.01% | +266.7% |
| Q1 2018 | $2,937,000 | +268.5% | 33,194 | +233.0% | 0.00% | +200.0% |
| Q4 2017 | $797,000 | +174.8% | 9,968 | +141.2% | 0.00% | – |
| Q3 2017 | $290,000 | -77.1% | 4,133 | -80.0% | 0.00% | -100.0% |
| Q2 2017 | $1,266,000 | -8.1% | 20,684 | -9.7% | 0.00% | 0.0% |
| Q3 2016 | $1,377,000 | -78.4% | 22,913 | -81.9% | 0.00% | -81.8% |
| Q2 2016 | $6,375,000 | +89.6% | 126,916 | +103.7% | 0.01% | +83.3% |
| Q1 2016 | $3,363,000 | -39.8% | 62,307 | -33.8% | 0.01% | -40.0% |
| Q4 2015 | $5,588,000 | – | 94,117 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| P2 Capital Partners, LLC | 850,000 | $43,155,000 | 5.33% |
| Hawk Ridge Capital Management | 1,276,955 | $64,831,000 | 4.07% |
| Paradice Investment Management LLC | 885,646 | $44,964,000 | 3.83% |
| Redmile Group, LLC | 1,536,362 | $78,001,000 | 3.03% |
| Greenlight Capital | 812,400 | $41,246,000 | 2.92% |
| Sachem Head Capital | 1,535,000 | $77,932,000 | 2.90% |
| Clearline Capital LP | 443,283 | $22,505,000 | 2.69% |
| EMINENCE CAPITAL, LP | 2,089,545 | $106,086,000 | 2.22% |
| HealthCor Management, L.P. | 328,030 | $16,654,000 | 2.08% |
| Atika Capital Management LLC | 3,831 | $19,450,000 | 1.65% |